• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Statins for primary prevention may reduce morbidity and mortality in elderly

byKenan Celtik, MSandSai Folmsbee
April 21, 2015
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A computer simulation shows that the use of statins for primary prevention in those older than 75 years of age may reduce coronary heart disease-related morbidity and mortality.

2. The net cost benefit of all primary prevention strategies in the elderly were highly dependent on the assumptions made regarding functional limitation and cognitive impairment due to statin use.

Evidence Rating Level: 2 (Good)

Study Rundown: The guidelines for the use of statins, a class of cholesterol-lowering drugs, in people over 75 years old are inconsistent and little is known about their effectiveness in primary prevention. In this study, a computer model was employed to study the effect of statin-based primary prevention strategies in 75 to 94 year-old Americans without cardiovascular disease (CVD) over 10 years, as compared to secondary prevention in people with existing CVD. Over the next 10 years, the model predicted that these elderly Americans will experience 2.5 million myocardial infarctions, 3.1 million coronary heart disease-related deaths, and accumulate $881 billion in CVD-related costs. The simulation showed that statins for primary prevention at three different LDL-cholesterol thresholds could avoid many of the MIs and CHD-related deaths, and may be cost-saving in some demographic subgroups when compared to secondary prevention. However, the cost-effectiveness of the primary prevention strategies was highly sensitive to small changes in the assumptions regarding adverse effect profile of statins. This was the major limitation of the study, as only the two most well-documented adverse effects were incorporated into the model, which may underestimate the overall burden of functional limitation due to statins.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.

In-Depth [computer simulation]: This study modeled the disease burden and cost-benefit of statins in 75 to 94 year-old individuals in the United States using the Cardiovascular Disease Policy Model. The effects of statins were based on 3 estimates using the PROSPER randomized trial results, and the Consumer Price Index was used to inflate costs to 2014 costs. Furthermore, drug costs were derived from the National Average Drug Acquisition Cost (NADAC) database, and the average of multiple studies was used to determine the prevalence of mild cognitive impairment and functional limitation from myopathy due to statin use. In this simulation, giving statins to all adults aged 75 to 94 with a history of cardiovascular disease (i.e., secondary prevention) who weren’t already using a statin prevented 53,000 MIs, avoided 85,000 CHD-deaths, gained 269,000 disability-adjusted life years (DALYs) and decreased societal costs by $14 billion. The primary prevention strategies tested were giving every person in the age group statins, only every person with diabetes, and only people with LDL-C levels of ≥4.91, ≥4.14 and ≥3.36.

RELATED REPORTS

Human papillomavirus vaccine effective in preventing infections in the United States

Unsweetened coffee consumption is associated with reduced risk of mortality

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: preventionstatins
Previous Post

Computerized clinical decision support may improve appropriate use of diagnostic radiology

Next Post

Normal thyrotropin levels not associated with coronary heart disease

RelatedReports

Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
European data showed coffee consumption associated with lower mortality
Cardiology

Unsweetened coffee consumption is associated with reduced risk of mortality

June 21, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Cardiology

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

April 7, 2022
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

Statin therapy initiation is associated with diabetes progression

October 8, 2021
Next Post
Shorter time to angioplasty may improve heart attack outcomes

Normal thyrotropin levels not associated with coronary heart disease

Opioid policy changes associated with decreased prescription overdose, increased heroin overdose

Opioid policy changes associated with decreased prescription overdose, increased heroin overdose

No association between MMR vaccination and autism regardless of baseline risk

No association between MMR vaccination and autism regardless of baseline risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
  • The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.